Panthera Biopartners has secured private equity investment from Lloyds Development Capital
Agosto 2025 — Panthera Biopartners had secured growth capital from Lloyds Development Capital Limited (LDC) to advance its geographic presence and enhance its clinical offering.
Panthera is one of the UK’s largest site management organizations (SMOs) for commercial clinical trials. Based in Preston, Lancashire, Panthera specializes in patient recruitment and the management of Phase II and Phase III clinical trials across a broad spectrum of therapeutic areas, including vaccines, cardiovascular medicine, diabetes, neurology, respiratory medicine, dermatology, rheumatology and early dementia. Its services span trial planning, data collection and patient retention. Operating six UK sites, Panthera conducts clinical trials for many of the world’s largest pharmaceutical companies and clinical research organizations (CROs).
LDC is a mid-market UK private equity firm. With LDC’s support, Panthera will seek to further expand its operations across the UK and Europe, increase the number of clinical sites, invest in technology and scale its trial delivery capabilities. As SMOs play an increasingly pivotal role in the drug development value chain, the business is well-positioned to capitalize on significant growth opportunities.
“We’re incredibly proud of what the team at Panthera has achieved and are excited to partner with LDC for this next phase of growth. Their investment will help us accelerate expansion, enhance our capabilities and continue delivering for our clients and patients. With LDC’s support and experience, we look forward to broadening our reach into Europe and expanding access to clinical trials across new regions,” said Stuart Young, CEO of Panthera.
Nuestro papel en la transacción
Oaklins S&W, based in the UK, acted as the management advisor to Panthera in securing private equity investment from LDC to support its ambitious growth strategy.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Dan Group Alarm Syd has been sold to Varna Security
Dan Group Alarm Syd, a leading provider of subscription-based security solutions, has been acquired by Varna Security, a newly formed security platform backed by Triton Partners. Through the transaction, Dan Group Alarm Syd enters into a new partnership with Triton Partners, positioning the company for its next phase of growth. As part of Varna Security, Dan Group Alarm Syd will continue to operate independently, retaining its entrepreneurial culture and close customer relationships, while gaining access to capital, resources and strategic support to accelerate expansion.
Aprenda másLivlande Agro has been acquired by Merito Partners
Merito Partners has acquired a controlling stake in Gaižēni SIA, one of Latvia’s leading pig farming companies operating under the Līvlande Agro brand, from NCH Capital and other shareholders. The company’s founder and management team will remain actively involved in the business, supporting its continued growth and development.
Aprenda másCensus Group has acquired Lecklé Oy
Backed by Swedish Aspira Partners, Census Group has acquired SYS Audit Oy, Lecklé Oy, Tiliextra Oy, Tase-Koivu Oy Tilintarkastusyhteisö, HJL Audit Oy and Auditus Tilintarkastus Oy. These transactions mark the creation of new platform in the Finnish audit and advisory services market. The newly formed group is jointly owned by Aspira Partners, entrepreneurs and key employees united by a shared vision and strong commitment to serving small and medium-sized enterprises (SMEs).
Aprenda más